breast cancer research

UTSW Spinout InterAct Therapeutics Selected by Cell & Gene Therapy Incubator Program

by | Dec 11, 2025
InterAct, which launched inside BioLabs at Pegasus Park, is a preclinical stage biotech company developing AAV8-based gene therapies for metastatic cancer, with an initial focus on breast cancer-derived liver metastases.
MORE
Mary Kay Ash Foundation Gives $500K Grant to Baylor Scott & White Health to Advance Breast Cancer Research and Early Detection
by | Dec 3, 2025
The grant is intended to accelerate a pioneering triple-negative breast cancer clinical trial that could advance early detection initiatives and shift care from reactive to proactive at the newly established Texas Cancer Interception Institute.
MORE